Metronidazole — $0 with Membership

Related medications

Other medications associated with the same conditions in this catalog.

Also listed for Bacterial Infections

• Amoxicillin
• Azithromycin
• Ciprofloxacin
• Doxycycline
• Levofloxacin

Also listed for Rosacea

• Azelaic Acid
• Ivermectin

Other medications in Dermatology

• Miconazole
• Mometasone Furoate Cream
• Mupirocin
• Mupirocin Ointment
• Nystatin Topical
• Permethrin
• Pimecrolimus
• Podophyllotoxin

About Metronidazole

Metronidazole is a powerful antibiotic and antiprotozoal medication widely prescribed to treat various bacterial and parasitic infections. If you've been prescribed metronidazole, TheDrugClub offers an incredible opportunity to get this essential medication with a $0 co-pay and the convenience of free home delivery, making your treatment journey smoother and more affordable.

Metronidazole, often known by its brand name Flagyl, is a versatile medication effective against a broad spectrum of anaerobic bacterial infections and certain parasitic infections. It's commonly prescribed for conditions such as bacterial vaginosis (BV), trichomoniasis (a common sexually transmitted infection), giardiasis, amebiasis, and certain dental infections. It also plays a crucial role in treating *Clostridioides difficile* (C. diff) infections, which can cause severe diarrhea, and is sometimes used as part of a regimen to eradicate *Helicobacter pylori* (H. pylori) in stomach ulcers. Its broad-reaching efficacy makes it a staple in many medical arsenals.

How Metronidazole Works

Metronidazole functions by disrupting the DNA of susceptible bacteria and parasites, preventing them from growing and reproducing. It's a "prodrug," meaning it becomes active only after it'

The information above is for educational purposes only and does not constitute medical advice. Consult your healthcare provider before making medication decisions.

What Metronidazole is approved for (FDA label)

Symptomatic Trichomoniasis. Metronidazole tablets are indicated for the treatment of T. vaginalis infection in females and males when the presence of the trichomonad has been confirmed by appropriate laboratory procedures (wet smears and/or cultures). Asymptomatic Trichomoniasis. Metronidazole tablets are indicated in the treatment of asymptomatic T. vaginalis infection in females when the organism is associated with endocervicitis, cervicitis, or cervical erosion. Since there is evidence that presence of the trichomonad can interfere with accurate assessment of abnormal cytological smears, additional smears should be performed after eradication of the parasite. Treatment of Asymptomatic Sexual Partners. T. vaginalis infection is a venereal disease.

Source: Read the full FDA label on DailyMed. Label effective date: August 26, 2026.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Boxed warning for Metronidazole (FDA label)

WARNING Metronidazole has been shown to be carcinogenic in mice and rats (see PRECAUTIONS ). Unnecessary use of the drug should be avoided. Its use should be reserved for the conditions described in the INDICATIONS AND USAGE section below.

Source: FDA prescribing information (DailyMed). Set ID: 4040db14-750f-6d20-e054-00144ff8d46c. SPL document ID: 59fbcd33-af2f-503f-e063-6294a90acbb9. Label effective date: August 26, 2026. Read the full label.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Adverse reactions for Metronidazole (FDA label)

The following reactions have been reported during treatment with metronidazole: Central Nervous System: The most serious adverse reactions reported in patients treated with metronidazole have been convulsive seizures, encephalopathy, aseptic meningitis, optic and peripheral neuropathy, the latter characterized mainly by numbness or paresthesia of an extremity. Since persistent peripheral neuropathy has been reported in some patients receiving prolonged administration of metronidazole, patients should be specifically warned about these reactions and should be told to stop the drug and report immediately to their physicians if any neurologic symptoms occur. In addition, patients have reported headache, syncope, dizziness, vertigo, incoordination, ataxia, confusion, dysarthria, irritability, depression, weakness, and insomnia (see WARNINGS ). Gastrointestinal: The most common adverse reactions reported have been referable to the gastrointestinal tract, particularly nausea, sometimes accompanied by headache, anorexia, and occasionally vomiting; diarrhea; epigastric distress; and abdominal cramping and constipation.

Source: FDA prescribing information (DailyMed). Set ID: 4040db14-750f-6d20-e054-00144ff8d46c. SPL document ID: 59fbcd33-af2f-503f-e063-6294a90acbb9. Label effective date: August 26, 2026. Read the full label.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Contraindications for Metronidazole (FDA label)

Hypersensitivity Metronidazole tablet are contraindicated in patients with a prior history of hypersensitivity to metronidazole or other nitroimidazole derivatives. In patients with trichomoniasis, metronidazole tablet are contraindicated during the first trimester of pregnancy (see PRECAUTIONS ). Psychotic Reaction with Disulfiram Use of oral metronidazole is associated with psychotic reactions in alcoholic patients who were using disulfiram concurrently. Do not administer metronidazole to patients who have taken disulfiram within the last two weeks (see PRECAUTIONS, Drug Interactions ). Interaction with Alcohol Use of oral metronidazole is associated with a disulfiram-like reaction to alcohol, including abdominal cramps, nausea, vomiting, headaches, and flushing. Discontinue consumption of alcohol or products containing propylene glycol during and for at least three days after therapy with metronidazole (see PRECAUTIONS, Drug Interactions ).

Source: FDA prescribing information (DailyMed). Set ID: 4040db14-750f-6d20-e054-00144ff8d46c. SPL document ID: 59fbcd33-af2f-503f-e063-6294a90acbb9. Label effective date: August 26, 2026. Read the full label.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Drug interactions for Metronidazole (FDA label)

Disulfiram Psychotic reactions have been reported in alcoholic patients who are using metronidazole and disulfiram concurrently. Metronidazole should not be given to patients who have taken disulfiram within the last two weeks (see CONTRAINDICATIONS ) . Alcoholic Beverages Abdominal cramps, nausea, vomiting, headaches, and flushing may occur if alcoholic beverages or products containing propylene glycol are consumed during or following metronidazole therapy (see CONTRAINDICATIONS ). Warfarin and other Oral Anticoagulants Metronidazole has been reported to potentiate the anticoagulant effect of warfarin and other oral coumarin anticoagulants, resulting in a prolongation of prothrombin time. When metronidazole is prescribed for patients on this type of anticoagulant therapy, prothrombin time and INR should be carefully monitored. Lithium In patients stabilized on relatively high doses of lithium, short-term metronidazole therapy has been associated with elevation of serum lithium and, in a few cases, signs of lithium toxicity.

Source: FDA prescribing information (DailyMed). Set ID: 4040db14-750f-6d20-e054-00144ff8d46c. SPL document ID: 59fbcd33-af2f-503f-e063-6294a90acbb9. Label effective date: August 26, 2026. Read the full label.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.